What is Zacks Research’s Estimate for CRL FY2026 Earnings?
Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) – Equities researchers at Zacks Research cut their FY2026 EPS estimates for Charles River Laboratories International in a research note issued to investors on Monday, June 2nd. Zacks Research analyst R. Department now anticipates that the medical research company will post earnings of $10.18 per share […]
